English
English Indonesia Türkçe Deutsch Español Português Pусский Français Italiano Nederlands Polski العربية ไทย Tiếng Việt 繁體中文 简体中文 日本語 한국어

#eylea search results

StanMehr's profile picture. For 30 years, Stan has been writing, editing, and presenting on a variety of health care topics, including biosimilars through his company and BR&R website.
Stanton Mehr
 @StanMehr
Jun 27, 2024

Compounded #bevacizumab owns > 50% of the retinal disorder market, costing much less than #Lucentis or #Eylea. What about compounded versions of the bevacizumab #biosimilars? Will retina specialists use them? A new report from @cardinalhealth says yes. wp.me/p7gt6c-7zw

0
0
2
0
83
StanMehr's profile picture. For 30 years, Stan has been writing, editing, and presenting on a variety of health care topics, including biosimilars through his company and BR&R website.
Stanton Mehr
 @StanMehr
Oct 29, 2024

On October 22, the federal appeals court denied @Regeneron’s request for an injunction against @Amgen pending appeal, which would have forestalled the biosimilar maker’s launch of #Pavglu, its biosimilar version of #Eylea. #aflibercept #biosimilars wp.me/p7gt6c-7PQ

0
1
2
0
141
JeffAdkins6's profile picture. Strategic Account Manager, Marketing Cloud - Enterprise HLS @Salesforce - Proud father of an 19yr old daughter, 2 dopey goldens, runner ...Tweets are my own
Jeff Adkins, MBA
 @JeffAdkins6
Jan 28, 2023

Great opportunity for marketing leadership role with a progressive organization. #regeneron #eylea #marketing #leadership lnkd.in/eRxDyiyZ

0
0
0
0
27
MunnimSaeed's profile picture.
ｷ尺乇乇 ㄎԾЦﾚ
 @MunnimSaeed
Feb 6, 2025

Dear Ministry of Health Maldives @MoHmv, Many Maldivians have been diagnosed with wet Age-Related Macular Degeneration (AMD). One of the few treatments to suppress or stabilize this eye condition is the administration of #Lucentis, #Accentrix, #Eylea or #Avastin 10 mg/mL

0
0
0
0
112
Papamicha007's profile picture. Hier Privat. #Vermögensverwaltung, #Kapitalmarkt, #Aktien insb. aus #Süddeutschland, Musik, #VfB, und was sonst noch Interessant ist 😎 #thinkglobalinvestlocal
Michael Mayer
 @Papamicha007
Jul 1, 2024

Next Step für #Formycon - #FDA erteilt Zulassung für #Eylea ®1)- #Biosimilar FYB203/AHZANTIVE®2) (Aflibercept-mrbb) eqs-news.com/de/news/adhoc/…

0
0
1
0
148
1stOncology's profile picture. Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.
1stOncology
 @1stOncology
Feb 10, 2023

#Regeneron World-Wide Sales for #EYLEA was 2335m USD in Q4 2022 (Down 5%) 1stoncology.com/blog/10-k-annu…

0
0
0
0
54
surgeonretina's profile picture. @Yale|@Harvard🎓| Surgeon•Scientist @NIH funded| Endowed Professor @UMich| #stemcell #cancer #epigenetics| #SoMe Editor @AAOjournal| https://t.co/CrzYIX4QHO
Rajesh Rao, MD
@surgeonretina
Aug 19, 2023

Interesting that as @US_FDA approves @Regeneron‘s high dose #Eylea, it also approves their complement C5 antibody #Veopoz near simultaneously - but the indication is for a ultra rare disease (CHAPLE- associated with CD55 mutations). “There are fewer than 10 patients with CHAPLE

0
3
8
0
2K
RetinaGlobal1's profile picture. An international nonprofit focused on sustainable solutions in retinal disease management in underserved areas around the world. #retina #eye #vision #sight
Retina Global
 @RetinaGlobal1
Jan 28, 2023

In a paper in @SciReports from #Japan, individualized treatment protocol with #Eylea (#aflibercept) that was based on the period of efficacy in treatment-naïve #BRVO eyes with macular edema was found to achieve satisfactory long-term visual outcome.

RetinaGlobal1's tweet image. In a paper in @SciReports from #Japan, individualized treatment protocol with #Eylea (#aflibercept) that was based on the period of efficacy in treatment-naïve #BRVO eyes with macular edema was found to achieve satisfactory long-term visual outcome.
1
3
12
0
1K
KRxVentures's profile picture. Helping you with #Ophthalmology, #Retina, #ClinDev, #Protocol, #TrialDesign, #MedAffairs, #Reg, #Research, #ReadingImages. Contact us @ krxventures@gmail.com
KRx Ventures, LLC
 @KRxVentures
May 21, 2024

The first #biosimilars to #Eylea have been approved by the FDA. bit.ly/4dKOin1 Pic (c) Center for Biosimilars

KRxVentures's tweet image. The first #biosimilars to #Eylea have been approved by the FDA. bit.ly/4dKOin1 Pic (c) Center for Biosimilars
1
1
0
0
42
NiceGuyAidey's profile picture. Ade Owen ... Aberteifi ... Views my own ... formally Welshade ... RiP JAC 16-09-23 .... Tom Green Fan.... Karl Pilkington Fan..People Say i'm Miserable .... Yes
AdeOwen
 @NiceGuyAidey
Dec 5, 2023

Eylea time again 🥴 thanks @NHS for excellent care as usual #Eylea

NiceGuyAidey's tweet image. Eylea time again 🥴 thanks @NHS for excellent care as usual #Eylea
1
0
2
0
103
hintondm's profile picture. Principal Educational Developer @unibirmingham @UoB_PGCHE, former Librarian #FaithLed #Bricoleur #learningdesign #SOTL #LTHEchat, PhD student HE @EdResLancaster
Danielle M Hinton, SFHEA 🇦🇺🇬🇧🇹🇿
 @hintondm
Sep 19, 2023

#PatientTip #Eylea #EyeInjection @NGHnhstrust 1 be compassionate and kind it makes a difference to us 2 as a patient you can feel the injection and eye becomes more tender as course progresses, be patient 3 tell patient what’s happening for each step, we aren’t being difficult

0
0
1
0
188
eyeadvocacy's profile picture. Eye surgeons partnering with policymakers in advocating for the American Academy of Ophthalmology’s patient-focused mission to protect sight and empower lives.
Eye Advocacy
@eyeadvocacy
Apr 26, 2024

BREAKING: @Regeneron announced a voluntary recall of specific lots of #eylea (aflibercept) injection due to potential syringe barrel breakage. No adverse events reported. Check your inventory and take action if affected. Contact [email protected] for details.

0
0
0
1
291
OphthTimes's profile picture. The leading content resource for #Ophthalmology | Follow us on Facebook: https://t.co/7wyuVtGM7t…
Ophthalmology Times
 @OphthTimes
Feb 9, 2023

BREAKING NEWS: FDA approves aflibercept (EYLEA) injection from Regeneron to treat preterm infants diagnosed with retinopathy of prematurity (ROP) Read more: ow.ly/9XGt50MO9nM #Ophthalmology #EYLEA @Regeneron @US_FDA

OphthTimes's tweet image. BREAKING NEWS: FDA approves aflibercept (EYLEA) injection from Regeneron to treat preterm infants diagnosed with retinopathy of prematurity (ROP) Read more: ow.ly/9XGt50MO9nM #Ophthalmology #EYLEA @Regeneron @US_FDA
1
6
26
2
4K
thepharmtales's profile picture. #Pharmtales brings you the latest and best in #pharma news, insights, and analysis. Follow us and get an information edge over the rest. #LatestPharmaNews
Pharmtales
 @thepharmtales
Aug 20, 2023

FDA Approves Eylea HD Injection 8 Mg For The Treatment Of Wet Age-Related Macular Degeneration, Diabetic Macular Edema, And Diabetic Retinopathy Read More: pharmtales.com/eylea-hd-injec… #Eylea @Regeneron #DiabeticRetinopathy #FDAapproval #pharmanews #pharmaupdates #Pharmtales

thepharmtales's tweet image. FDA Approves Eylea HD Injection 8 Mg For The Treatment Of Wet Age-Related Macular Degeneration, Diabetic Macular Edema, And Diabetic Retinopathy Read More: pharmtales.com/eylea-hd-injec… #Eylea @Regeneron #DiabeticRetinopathy #FDAapproval #pharmanews #pharmaupdates #Pharmtales
0
3
3
0
75
omegapharmacies's profile picture. Omega represents independent pharmacies, leveraging our buying power to help pharmacies access pharmaceuticals at the best prices.
Omega Pharmacy Group
 @omegapharmacies
Jul 3, 2024

FDA approves Ahzantive (aflibercept-mrbb), a biosimilar to Eylea (aflibercept): #FDA #biosimilar #Eylea #pharmacy #independentpharmacy linkedin.com/posts/omega-ph…

omegapharmacies's tweet image. FDA approves Ahzantive (aflibercept-mrbb), a biosimilar to Eylea (aflibercept): #FDA #biosimilar #Eylea #pharmacy #independentpharmacy linkedin.com/posts/omega-ph…
0
0
0
0
16
MedPipeline's profile picture. Leigh Anderson, PharmD. She/Her 🌎 US #Pharmacist bringing global #medical & drug info | @UNC @RiceUniversity @UGA @UF | Posts Not Medical, Medication Advice
MedPipeline
 @MedPipeline
Mar 18

Eylea Patient Tips: 7 Things You Should Know Drugs.com #Eylea and Eylea HD both contain aflibercept and are VEGF (vascular endothelial growth factor) inhibitors used to treat retinal eye diseases that may seriously affect your vision. drugs.com/tips/eylea-pat…

0
0
0
0
14
MedPipeline's profile picture. Leigh Anderson, PharmD. She/Her 🌎 US #Pharmacist bringing global #medical & drug info | @UNC @RiceUniversity @UGA @UF | Posts Not Medical, Medication Advice
MedPipeline
 @MedPipeline
Mar 9

What is the difference between Eylea and #Eylea HD? Drugs.com Both are ocular injections used to treat various retinal diseases of the eyes, and work the same way, but do they have the same uses? drugs.com/medical-answer…

0
0
0
0
13
MedPipeline's profile picture. Leigh Anderson, PharmD. She/Her 🌎 US #Pharmacist bringing global #medical & drug info | @UNC @RiceUniversity @UGA @UF | Posts Not Medical, Medication Advice
MedPipeline
 @MedPipeline
Feb 27

Eylea: 7 Patient Tips to Know Drugs.com When levels of the VEGF protein are elevated in your eyes, it can cause blood vessels to swell, leak fluid and cause formation of abnormal blood vessels. This can cause damage to your retina. drugs.com/tips/eylea-pat… #Eylea

0
0
0
0
20
Healio_OSN's profile picture. The content you need, when you need it.
Ocular Surgery News
 @Healio_OSN
Feb 20

Under the terms of a settlement and license agreement with @Regeneron: @SamsungBioepis will be able to launch Opuviz, a #biosimilar to #Eylea, in the U.S. in January 2027. More on @goHealio:🔗 vist.ly/4s9z6

Healio_OSN's tweet card. Under the terms of a settlement and license agreement with Regeneron, Samsung Bioepis will be able to launch Opuviz in the U.S. in January 2027, according to a press release.“As with ranibizumab...
Samsung Bioepis, Regeneron reach settlement on aflibercept biosimilar
Source: healio.com
0
0
2
0
169
BioWorld's profile picture. Biopharma’s trusted news source
BioWorld
@BioWorld
Feb 17

Eylea threatened Inlyta Ocular’s phase III win with Axpaxli? bioworld.com/articles/728992 #biopharma @OCUTX #AMD #Eylea #REGN #OCUL

0
0
3
0
422
Healio_OSN's profile picture. The content you need, when you need it.
Ocular Surgery News
 @Healio_OSN
Feb 14

❗BREAKING❗ Under the terms of a settlement and license agreement, @SamsungBioepis can launch #Opuviz in the U.S. starting in January 2027. Opuviz is a #biosimilar to #Eylea from @Regeneron. 🔗👇 vist.ly/4rk6j @gohealio

Healio_OSN's tweet card. Under the terms of a settlement and license agreement with Regeneron, Samsung Bioepis will be able to launch Opuviz in the U.S. in January 2027, according to a press release.“As with ranibizumab...
Samsung Bioepis, Regeneron reach settlement on aflibercept biosimilar
Source: healio.com
0
0
0
0
147
RetinaSERV's profile picture. Asociación científica, sin animo de lucro, que tiene por objeto fomentar el estudio de las enfermedades de la retina, coroides y vítreo.
Sociedad Española de Retina y Vítreo
 @RetinaSERV
Feb 7

Perfil de seguridad favorable y control de fluido equivalente. Para retinólogos, una herramienta clave en manejo eficiente de OVR.  Para obtener más información, consulta la noticia completa en nuestro enlace. 💉 🔬👁️ #Retinología #Oftalmología #Eylea #OVR

0
0
0
0
77
Gil123q's profile picture. I am a retired research scientist and research at home. My main focus is #AMD. For relaxation I work as an artist. Views my own #eyes #vision #research #art
Dr Owen
 @Gil123q
Feb 1

Instead of creating a super-wet AMD antibody targeting too many proteins, which may be impossible to develop, an anti-VEGF drug-loaded syringe could contain proportions of engineered humanised Fab fragments as decoys for ANG-2, VEGF-A, VEGF-B and PlGF. #wetAMD #Eylea #Vabysmo

0
0
0
0
52
Gil123q's profile picture. I am a retired research scientist and research at home. My main focus is #AMD. For relaxation I work as an artist. Views my own #eyes #vision #research #art
Dr Owen
 @Gil123q
Jan 31

We need to take the best aspects of anti-VEGF eye injections: Ang-2 #Vabysmo, anti-VEGF-B and PlGF #Eylea. Remove the Fc unit as in #Ranibizumab to reduce systemic side effects (also limits entry into RPE cells), thus creating a better treatment for wet AMD. All anti-VEGF A

0
0
0
0
146
shiningrx57's profile picture. The Pharma export Company Link for Edegra- https://t.co/vTyEJcJCRO Sinegra- https://t.co/NXJ76m9cMx
Shining Thread Associate
 @shiningrx57
Jan 17

Now available: EYLEA® Injection 👁️ Aflibercept 40 mg/mL 📩 Contact ShiningRx for bulk orders. #Eylea #Aflibercept #Ophthalmology #PharmaExports #ShiningRx shiningrx.com/product/eylea-…

shiningrx57's tweet image. Now available: EYLEA® Injection 👁️ Aflibercept 40 mg/mL 📩 Contact ShiningRx for bulk orders. #Eylea #Aflibercept #Ophthalmology #PharmaExports #ShiningRx shiningrx.com/product/eylea-…
0
0
0
0
7
RaviParikhMD's profile picture. Physician. Retina Specialist. Public Health/Policy Advocate. Chairman @ManhattanRetinaEye, Faculty @OrbisIntl, @NYULangone, Trained @Harvard, @Yale, @Vanderbilt
Ravi Parikh, MD MPH
 @RaviParikhMD
Jan 15

First research publication of the new year ! (1 of 3) In the US for retinal diseases #vabysmo has the highest rate of absolute and relative increase in adoption while #eylea is the most commonly used drug. Lower cost avastin is declining journals.plos.org/plosone/articl… #medtwitter

1
1
3
0
252
chaperonycon's profile picture. Biotech investor with a strong focus on biosimilars and biobetters. Innovation needs the pressure from patent cliffs.
SpeedyGonzalesi
 @chaperonycon
Jan 10

„Regional Court Munich grants PI to Regeneron against generics in Eylea case.“ eylea ip formulation prevents biosim competition in most of europe. settlement agreement needed. #formycon #biosimilars #eylea juve-patent.com/cases/regional…

chaperonycon's tweet card. Regeneron and Bayer have successfully defended their ophthalmic drug Eylea at Munich Regional Court as judges grant PI against generics.
Regional Court Munich grants PI to Regeneron against generics in Eylea case
Source: juve-patent.com
0
0
0
0
56
DIKAJOB's profile picture. DikaJob - Social network for Pharma, Biotech and Life Sciences
DikaJob
 @DIKAJOB
Dec 4

Injeção #EYLEA HD® (#aflibercepto) 8 mg aprovada pela @US_FDA para o tratamento do edema macular após oclusão da veia retiniana (RVO) Saiba mais... dikajob.com.br/profiles/blogs… #dikajob #pharma #pharmaceutical #dkprime #jonimengaldo #regeneron @Regeneron @joaomengaldo

DIKAJOB's tweet image. Injeção #EYLEA HD® (#aflibercepto) 8 mg aprovada pela @US_FDA para o tratamento do edema macular após oclusão da veia retiniana (RVO) Saiba mais... dikajob.com.br/profiles/blogs… #dikajob #pharma #pharmaceutical #dkprime #jonimengaldo #regeneron @Regeneron @joaomengaldo
0
0
0
0
30
Gil123q's profile picture. I am a retired research scientist and research at home. My main focus is #AMD. For relaxation I work as an artist. Views my own #eyes #vision #research #art
Dr Owen
 @Gil123q
Nov 23

Switching from #Eylea HD to #Vabysmo, the NHS requires a monthly loading period again. However, if the SRF and intraretinal fluid are barely visible, why put a patient through these extra injections? Vabysmo may dry this fluid when Eylea is not, allowing for an extension.

0
0
0
0
67
pharma_eu's profile picture. Pharma Focus Europe examines significant concerns and advancements influencing the pharma industry's future in Europe and the rest of the world.
Pharma Focus Europe
 @pharma_eu
Oct 19, 2024

New #ClinicalTrial results! @Bayer & Regeneron’s PHOTON study shows #Eylea 8mg offers sustained vision improvement for DME patients w/ fewer treatments over 3 years! pharmafocuseurope.com/pressreleases/… #Ophthalmology #DME #VisionCare #MedicalInnovation

pharma_eu's tweet image. New #ClinicalTrial results! @Bayer & Regeneron’s PHOTON study shows #Eylea 8mg offers sustained vision improvement for DME patients w/ fewer treatments over 3 years! pharmafocuseurope.com/pressreleases/… #Ophthalmology #DME #VisionCare #MedicalInnovation
0
0
0
0
50
thepharmtales's profile picture. #Pharmtales brings you the latest and best in #pharma news, insights, and analysis. Follow us and get an information edge over the rest. #LatestPharmaNews
Pharmtales
 @thepharmtales
Jun 30, 2023

REGENERON HAS FACED AN UNEXPECTED REJECTION FROM THE FDA FOR ITS HIGH-DOSE VERSION OF EYLEA DUE TO MANUFACTURING CHALLENGES zurl.co/ELdO . . . #Eylea #FDA #Regeneron #wet #macular #degeneration #pharmaindustry #pharmanews #pharmaupdates #pharmtales

thepharmtales's tweet image. REGENERON HAS FACED AN UNEXPECTED REJECTION FROM THE FDA FOR ITS HIGH-DOSE VERSION OF EYLEA DUE TO MANUFACTURING CHALLENGES zurl.co/ELdO . . . #Eylea #FDA #Regeneron #wet #macular #degeneration #pharmaindustry #pharmanews #pharmaupdates #pharmtales
0
0
0
0
42
thepharmtales's profile picture. #Pharmtales brings you the latest and best in #pharma news, insights, and analysis. Follow us and get an information edge over the rest. #LatestPharmaNews
Pharmtales
 @thepharmtales
Aug 20, 2023

FDA Approves Eylea HD Injection 8 Mg For The Treatment Of Wet Age-Related Macular Degeneration, Diabetic Macular Edema, And Diabetic Retinopathy Read More: pharmtales.com/eylea-hd-injec… #Eylea @Regeneron #DiabeticRetinopathy #FDAapproval #pharmanews #pharmaupdates #Pharmtales

thepharmtales's tweet image. FDA Approves Eylea HD Injection 8 Mg For The Treatment Of Wet Age-Related Macular Degeneration, Diabetic Macular Edema, And Diabetic Retinopathy Read More: pharmtales.com/eylea-hd-injec… #Eylea @Regeneron #DiabeticRetinopathy #FDAapproval #pharmanews #pharmaupdates #Pharmtales
0
3
3
0
75
DIKAJOB's profile picture. DikaJob - Social network for Pharma, Biotech and Life Sciences
DikaJob
 @DIKAJOB
Dec 4

Injeção #EYLEA HD® (#aflibercepto) 8 mg aprovada pela @US_FDA para o tratamento do edema macular após oclusão da veia retiniana (RVO) Saiba mais... dikajob.com.br/profiles/blogs… #dikajob #pharma #pharmaceutical #dkprime #jonimengaldo #regeneron @Regeneron @joaomengaldo

DIKAJOB's tweet image. Injeção #EYLEA HD® (#aflibercepto) 8 mg aprovada pela @US_FDA para o tratamento do edema macular após oclusão da veia retiniana (RVO) Saiba mais... dikajob.com.br/profiles/blogs… #dikajob #pharma #pharmaceutical #dkprime #jonimengaldo #regeneron @Regeneron @joaomengaldo
0
0
0
0
30
Healio_OSN's profile picture. The content you need, when you need it.
Ocular Surgery News
 @Healio_OSN
Dec 17, 2024

The CHMP of the European Medicines Agency granted a positive opinion for @Celltrioninc's Eydenzelt, a biosimilar to #Eylea. Read more👇 #OcularSurgeryNews #Ophthalmology #Retina @EMA_News healio.com/news/ophthalmo…

Healio_OSN's tweet image. The CHMP of the European Medicines Agency granted a positive opinion for @Celltrioninc's Eydenzelt, a biosimilar to #Eylea. Read more👇 #OcularSurgeryNews #Ophthalmology #Retina @EMA_News healio.com/news/ophthalmo…
0
0
1
0
153
DanniReprints's profile picture. Improve marketing/educate your salesforce with reprint/eprints from Elsevier, Lancet, AJP, ACP, T & F and Dove, danni.morinich@contentednet.com
Danni Morinich-Content Ed Net US
 @DanniReprints
May 1, 2024

New reprints for #Eylea: Switching to the aflibercept (3 mg) therapy for treatment-resistant wet age-related macular degeneration: 1-year outcomes @regeneron #wetAMD

DanniReprints's tweet image. New reprints for #Eylea: Switching to the aflibercept (3 mg) therapy for treatment-resistant wet age-related macular degeneration: 1-year outcomes @regeneron #wetAMD
0
0
0
0
64
NiceGuyAidey's profile picture. Ade Owen ... Aberteifi ... Views my own ... formally Welshade ... RiP JAC 16-09-23 .... Tom Green Fan.... Karl Pilkington Fan..People Say i'm Miserable .... Yes
AdeOwen
 @NiceGuyAidey
Dec 5, 2023

Eylea time again 🥴 thanks @NHS for excellent care as usual #Eylea

NiceGuyAidey's tweet image. Eylea time again 🥴 thanks @NHS for excellent care as usual #Eylea
1
0
2
0
103
revoptom's profile picture. Optometry’s trusted advocate for the advancement of clinical expertise since 1891.
Review of Optometry
 @revoptom
May 13, 2024

High-dose Aflibercept Pushes Dosing Interval to Five Months Nearly half of subjects went 20 weeks or longer between injections with the 8mg formulation. The regimen also maintained BCVA gains out to 96 weeks. reviewofoptometry.com/article/highdo… #eylea #amd #retina #eyecare #optometry

revoptom's tweet image. High-dose Aflibercept Pushes Dosing Interval to Five Months Nearly half of subjects went 20 weeks or longer between injections with the 8mg formulation. The regimen also maintained BCVA gains out to 96 weeks. reviewofoptometry.com/article/highdo… #eylea #amd #retina #eyecare #optometry
0
0
9
1
856
BioLBioS2024's profile picture. 5th Euro-Global Summit on Future of Biologics and Biosimilars
BioL-BioS 2024
 @BioLBioS2024
Jun 1, 2024

US FDA approves two biosimilars for blockbuster eye drug Eylea Read more at: tinyurl.com/5n8926hr To acquire more information about biosimilars eye drug Eylea join us at BioL-BioS 2024 via: …biosimilars.peersalleyconferences.com #biosimilars #Eylea #drug

BioLBioS2024's tweet image. US FDA approves two biosimilars for blockbuster eye drug Eylea Read more at: tinyurl.com/5n8926hr To acquire more information about biosimilars eye drug Eylea join us at BioL-BioS 2024 via: …biosimilars.peersalleyconferences.com #biosimilars #Eylea #drug
0
0
1
0
28
OphthTimes's profile picture. The leading content resource for #Ophthalmology | Follow us on Facebook: https://t.co/7wyuVtGM7t…
Ophthalmology Times
 @OphthTimes
Feb 9, 2023

BREAKING NEWS: FDA approves aflibercept (EYLEA) injection from Regeneron to treat preterm infants diagnosed with retinopathy of prematurity (ROP) Read more: ow.ly/9XGt50MO9nM #Ophthalmology #EYLEA @Regeneron @US_FDA

OphthTimes's tweet image. BREAKING NEWS: FDA approves aflibercept (EYLEA) injection from Regeneron to treat preterm infants diagnosed with retinopathy of prematurity (ROP) Read more: ow.ly/9XGt50MO9nM #Ophthalmology #EYLEA @Regeneron @US_FDA
1
6
26
2
4K
doepke_michel's profile picture. Redakteur beim @aktionaer, articles: https://t.co/aD9LxlAUrm
Michel Doepke
@doepke_michel
Dec 12, 2024

$BBIO $BAYN Acoramidis CHMP opinion imminent. Also #Eylea should be the focus of #Bayer. ema.europa.eu/en/documents/a…

doepke_michel's tweet image. $BBIO $BAYN Acoramidis CHMP opinion imminent. Also #Eylea should be the focus of #Bayer. ema.europa.eu/en/documents/a…
0
0
2
0
1K
BMJ_Ophth's profile picture. News and research updates from BMJ Open Ophthalmology and British Journal of Ophthalmology for ophthalmologists and vision scientists from BMJ.
Ophthalmology at BMJ
@BMJ_Ophth
Sep 11, 2024

9-year study shows long-term benefits of treat-and-extend protocol for #CRVO! Patients treated with aflibercept (#Eylea) maintained stable vision gains (avg +31.6 letters) and reduced macular edema. Treatment intervals were typically extended to 13 weeks by year 8. Read here:

BMJ_Ophth's tweet image. 9-year study shows long-term benefits of treat-and-extend protocol for #CRVO! Patients treated with aflibercept (#Eylea) maintained stable vision gains (avg +31.6 letters) and reduced macular edema. Treatment intervals were typically extended to 13 weeks by year 8. Read here:
0
1
0
0
344
Drugscom's profile picture. Keeping you up-to-date with the latest medication news, FDA Medwatch alerts and new drug approvals.
Drugs.com
 @Drugscom
Feb 12, 2025

What is the difference between #Vabysmo and #Eylea? bit.ly/3IVJttW

Drugscom's tweet image. What is the difference between #Vabysmo and #Eylea? bit.ly/3IVJttW
0
2
0
0
290
Pharmashot's profile picture. PharmaShots | Your partner in biopharma & healthcare insights. Connecting decision-makers & brands through sharp news, impactful insights and leader interviews
PharmaShots | Iluminate.Innovate.Inspire
 @Pharmashot
Feb 10, 2025

Regeneron Reports Data from Extended P-III (PULSAR) Trial of Eylea for Wet Age-related Macular Degeneration pharmashots.com/21002/regenero… #regeneron #eylea #wetagerelatedmaculardegeneration #clinicaltrial #pharmashots

Pharmashot's tweet image. Regeneron Reports Data from Extended P-III (PULSAR) Trial of Eylea for Wet Age-related Macular Degeneration pharmashots.com/21002/regenero… #regeneron #eylea #wetagerelatedmaculardegeneration #clinicaltrial #pharmashots
0
0
0
0
48
JaviFarn's profile picture. Let's discuss market outlooks and trading tips. @mexexchange
Javi Farn
 @JaviFarn
Sep 27

$REGN eye drug trial succeeds. #Eylea successor due 2026. Patent cliff pushed out.

JaviFarn's tweet image. $REGN eye drug trial succeeds. #Eylea successor due 2026. Patent cliff pushed out.
0
0
0
0
20
javierascaso's profile picture. Oftalmólogo de la Corona d Aragón. Familiar, hogareño y viajero. Amo la naturaleza. No juego a la lotería xq me tocó el día que conocí a Isabel. Zaragoza, Spain
Javier Ascaso
 @javierascaso
Jun 26

Gracias a @BayerPharma por invitarme a presentar la experiencia del servicio de oftalmología del Hospital Clínico Universitario Lozano Blesa de Zaragoza con #Eylea 8mg en #DMAE neovascular y #edemamacular diabético @medicoszaragoza @oftalmologiaSAO @OftalmologiaSEO @RetinaSERV

javierascaso's tweet image. Gracias a @BayerPharma por invitarme a presentar la experiencia del servicio de oftalmología del Hospital Clínico Universitario Lozano Blesa de Zaragoza con #Eylea 8mg en #DMAE neovascular y #edemamacular diabético @medicoszaragoza @oftalmologiaSAO @OftalmologiaSEO @RetinaSERV
javierascaso's tweet image. Gracias a @BayerPharma por invitarme a presentar la experiencia del servicio de oftalmología del Hospital Clínico Universitario Lozano Blesa de Zaragoza con #Eylea 8mg en #DMAE neovascular y #edemamacular diabético @medicoszaragoza @oftalmologiaSAO @OftalmologiaSEO @RetinaSERV
0
0
0
0
75

Something went wrong.


Something went wrong.


United States Trends